Withdrawal Notice: Investigating the Anti-Angiogenic Effects of Elaeagnus angustifolia L. Extract In Vivo

Title:Withdrawal Notice: Investigating the Anti-Angiogenic Effects of Elaeagnus angustifolia L. Extract In Vivo

Volume: 9

Author(s): Mohammad Sako , Malek Zihlif*Fatma Afifi

Affiliation:

• Department of Pharmacology, School of Medicine, The University of Jordan, Amman,Jordan

Abstract: The article has been withdrawn at the request of the authors of the journal Clinical Cancer Drugs.

Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.

The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php

BENTHAM SCIENCE DISCLAIMER:

It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submit-ting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Cite this article as:

Sako Mohammad, Zihlif Malek*, Afifi Fatma, Withdrawal Notice: Investigating the Anti-Angiogenic Effects of Elaeagnus angustifolia L. Extract In Vivo, Clinical Cancer Drugs 2022; 9 () : e060921196183 . https://dx.doi.org/10.2174/2212697X08666210906124143